Domov › Nemalobunkový karcinóm pľúc › Kalifornia › Irvine
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Irvine, CA
25 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Irvine a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 3
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 2/3
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Kaiser Permanente-Irvine, Irvine
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Prebieha náborFáza 1
- City of Hope at Irvine Lennar, Irvine
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
Prebieha náborFáza 2
- City of Hope 1, Irvine
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 2
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Prebieha náborFáza 2/3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building, Irvine
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Prebieha náborFáza 1
- Hoag Memorial Hospital Presbyterian, Irvine
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- UCI Health-CIACC, Irvine
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Prebieha náborFáza 3
- Research Site, Irvine
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Prebieha náborFáza 1/2
- City of Hope, Irvine
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Prebieha náborFáza 2
- City of Hope at Irvine Lennar, Irvine
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Prebieha náborFáza 1/2
- The Regents of the University of California - Irvine, CA Campus, Irvine
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Prebieha náborFáza 1
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Prebieha náborFáza 3
- City of Hope at Irvine Lennar, Irvine
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- City of Hope - Lennar, Irvine
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Prebieha náborFáza 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589, Irvine
Study of XB010 in Subjects With Solid Tumors
Prebieha náborFáza 1
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- City of Hope at Irvine Lennar, Irvine
- Kaiser Permanente-Irvine, Irvine
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Prebieha náborFáza 2
- City of Hope at Irvine Lennar, Irvine
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Prebieha náborFáza 1/2
- University of California, Irvine, Irvine
Carfilzomib in Combination With Sotorasib for the Treatment of Patients With KRAS G12C Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Prebieha náborFáza 1
- City of Hope at Irvine Lennar, Irvine
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
Prebieha náborFáza 2
- City of Hope at Irvine Lennar, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Irvine
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Arlington, VA104 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
Iné štúdie v Irvine
- Rakovina prsníka23 štúdií
- Rakovina (všetky typy)17 štúdií
- Metastatická rakovina16 štúdií
- Rakovina pľúc15 štúdií
- Mnohonásobný myelóm14 štúdií
- Rakovina prostaty14 štúdií
- Rakovina vaječníkov12 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku11 štúdií
- Rakovina močového mechúra11 štúdií
- Alzheimerova choroba11 štúdií
- Kolorektálny karcinóm10 štúdií
- Rakovina pankreasu10 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.